Table 3. Difference in parasitological outcomes between the arms- unadjusted and adjusted for age, gestation, initial parasitaemia and haemogobin.
Unadjusted odds ratios (95%CI) | Sig p | Adjusted odds ratios (95%CI) | Sig p | Unadjusted relative risk ((95%CI)) | |
AQ+SP v AQ+AS | 0.13 (0.02–1.1) | 0.06 | 0.13 (0.015–1.1) | 0.06 | 0.15 (0.02–1.2) |
AQ+SP v SP1 | 0.08 (0.005–0.7) | 0.025 | 0.06 (0.006–0.6) | 0.02 | 0.09 (0.01–0.76) |
AQ+SP v CD2 | 0.046 (0.006–0.36) | 0.003 | 0.046 (0.005–0.36) | 0.004 | 0.06 (0.008–0.43) |
AQ+AS v SP | 0.56 (0.15–2.1) | 0.4 | 0.61 (0.16–2.4) | 0.47 | 0.61 (0.19–1.9) |
AQ+AS v CD3 | 0.34 (0.13–0.86) | 0.02 | 0.36 (0.14–0.94) | 0.04 | 0.40 (0.18–0.90) |
SP v CD | 0.60 (0.18–2.0) | 0.4 | 0.57 (0.16–2.0) | 0.4 | 0.66 (0.2–1.8) |
Best arm first in each pairwise comparison, without PCR adjustment.
AQ+SP significantly better than SP.
AQ+SP significantly better than CD.
AQ+AS significantly better than CD.